西欧与东欧之间持续存在的癌症死亡率差距
该研究基于世界卫生组织官方死亡率数据库,用Joinpoint回归分析欧洲西部与东部国家的癌症死亡率趋势。结果显示,自1990年以来西欧癌症死亡率每年下降1%–1.4%,而东欧男性约在2000年代才开始下降、女性保持稳定,东欧相对西欧的死亡率超额从男性32%升至37%、女性15%升至21%。作者认为生活方式(主要是吸烟和饮酒)及癌症诊疗改善推广不同是差距持续的关键决定因素,且无证据表明差距在缩小。
要点
- 2016年西欧年龄标化癌症死亡率为男性125.4/10万、女性81.3/10万,东欧为男性171.9/10万、女性98.2/10万。
- 东欧相对西欧的癌症死亡率超额从男性32%升至37%、女性15%升至21%。
核心结论
- 生活方式差异(主要是吸烟和饮酒)以及癌症诊断和管理改善推广不同,是西欧与东欧癌症死亡率持续差距的关键决定因素。
- 原文指出没有证据表明这一差距正在缩小。
研究设计与样本
- 研究使用世界卫生组织官方死亡率数据库计算西欧和东欧国家的癌症死亡率。
- 采用Joinpoint回归模型识别死亡率随时间变化的显著趋势转折。
主要发现
- 自1990年以来,西欧癌症死亡率每年下降1%–1.4%,2016年年龄标化(世界标准)死亡率达到男性125.4/10万、女性81.3/10万。
- 东欧男性死亡率约在2000年代才开始下降,女性死亡率保持稳定,2016年达到男性171.9/10万、女性98.2/10万。
- 肺癌死亡率在西欧为男性30.8/10万、女性14/10万,在东欧为男性47.1/10万、女性15.2/10万。
- 东欧相对西欧的死亡率超额从男性32%升至37%、女性15%升至21%。
- 男性超额百分比最大的癌种为上呼吸道、胃、肠道和肺癌,女性为子宫癌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Over the last three decades, cancer mortality has shown favourable patterns in Europe. Patterns and trends however have been less favourable for most eastern countries. METHODS: We computed cancer mortality rates in western (WE) and eastern European (EE) countries using the official mortality database of the World Health Organisation, using joinpoint regression models to identify significant changes in trends over time. RESULTS: Cancer mortality declined by 1-1.4% annually in WE since 1990, to reach an age-standardised rate (world standard) of 125.4/100,000 men and 81.3/100,000 women in 2016. In contrast, EE rates only started to decline around the 2000s in men and remained stable in women, to reach 171.9/100,000 men and 98.2/100,000 women. Lung cancer rates were 30.8/100,000 men and 14/100,000 women in WE versus 47.1/100,000 men and 15.2/100,000 women in EE. In relative terms, the mortality excess in EE increased from 32 to 37% in men and from 15 to 21% in women, compared with WE. The largest percent excesses were for cancers of the upper respiratory tract, stomach, intestines and lung in men and uterus in women. Prostate cancer rates increased in EE to reach 12.7/100,000 in 2016, whereas they decreased to 10.2/100,000 in WE. Compared with rates in 1990, over the period 1991-2016, about 3.9 million cancer deaths were avoided in WE, but no notable improvements was seen in EE. If cancer mortality rates in EE had been those observed in WE, over 55,000 deaths would have been avoided in 2016. CONCLUSION: Differences in lifestyle patterns, mainly smoking and alcohol, besides different roll-out of improvements in cancer diagnosis and management are the key determinants of the persisting difference in cancer mortality between western and eastern Europe. There is no evidence for the gap to close.
引用
- Santucci C, Patel L, Malvezzi M, et al. Persisting cancer mortality gap between western and eastern Europe. Eur J Cancer. 2022. PMID: 35189536. doi:10.1016/j.ejca.2022.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。